Calcineurin Inhibitors Replacement by Ruxolitinib as Graft Versus Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation.Biol Blood Marrow Transplant.(2020).
Corrigendum to 'Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractor.Biol Blood Marrow Transplant.(2019).
Determining whether prophylactic antiviral treatment is necessary in HBsAg-negative/HBcAb-positive patients receiving allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.(2020).
Electro-Acupuncture Promotes Endogenous Multipotential Mesenchymal Stem Cell Mobilization into the Peripheral Blood.Cell Physiol Biochem38, 1605-1617.(2016).
Exogenous IL-4-Expressing Bone Marrow Mesenchymal Stem Cells for the Treatment of Autoimmune Sensorineural Hearing Loss in a Guinea Pig Model.Biomed Res Int2014, 856019.(2014).
Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.Cancer Biol Ther15.(2014).
The incidence, Risk factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant.(2019).
NR2F2 regulates bone marrow-derived mesenchymal stem cell-promoted proliferation of Reh cells.Mol Med Rep.(2016).
The Plasticity of Mesenchymal Stem Cells in Regulating Surface HLA-I.Iscience15, 66-78.(2019).
The Prodomain-Containing BMP9 Produced from a Stable Line Effectively Regulates the Differentiation of Mesenchymal Stem Cells.Int J Med Sci13, 8-18.(2016).
Sequential treatment combining cladribine-based re-induction, myeloablative allogeneic HSCT, and prophylactic donor lymphocyte infusion: a promising treatment for refractory acute myeloid leukemia.Ann Hematol.(2018).